Trigeminal neuralgia is sudden, severe facial pain. It's often described as a sharp shooting pain or like having an electric shock in the jaw, teeth or gums.
Trigeminal neuralgia
Contents
Overview
Symptoms
Causes
Diagnosis
Treatment
13. • Annual incidence 4-5 patients per 100,000 population.
• Highest incidence between 50 & 70 years of age.
• Estimated 2% of multiple sclerosis patients complain of TN.
• Roughly 15,000 new cases annually in the United States.
• Most cases are sporadic.
van Kleef M et al. Pain Practice. 2009;9:252-259.
Rozen TD. Neurol Clin. 2004;22:185-206.
Katusic S et al. Neuroepidemiology. 1991;10:276-281.
Obermann M et al. Expert Review of Neuropathics. 2009;7:323-329.
Rozen TD et al. Wolff's Headache and Other Head Pain. Oxford University Press, 2001.
Fleetwood IG et al. J Neurosurg. 2001;95:513-517.
Incidence of Trigeminal Neuralgia
14. 0
5
10
15
20
25
30
2nd 3rd 4th 5th 6th 7th 8th 9th
Decade
Age of Onset
• 90% of cases occur after age 40.
• More prevalent in women then men 1.5-2 : 1 ratio.
• More than 70% of patients with TN are over 50 years of age at the time
onset.
Rozen TD. Neurol Clin. 2004;22:185-206.
18. • Pain is brief (Seconds to 1-2 minutes) and paroxysmal, occur in
Several attacks, Stabbing or Shocklike and is typically Severe.
• Pain provokes brief muscle Spasm of the facial muscles, thus
producing the tic.
Clinical picture: pain
19. • Various triggers may commonly
precipitate a pain attack.
• Light touch or vibration is the most
provocative.
• Activities such as shaving, laughing,
brushing teeth and face washing.
Clinical picture: Trigger points
21. • 38 y old lady presented with recurrent
bouts of left sided paroxysmal facial pain
lasting for seconds.
• Provoked by brushing her teeth, eating,
or even talking.
• Her examination was entirely normal
apart from mild left sided facial
hypothesia.
Case 1
22. • Trigger point; may limit examination for fear of stimulating these points.
• The diagnosis of idiopathic TN is tenable only if no physical findings of fifth
nerve dysfunction are present.
Physical Examination
23. • Age younger than 40 years
• Bilateral symptoms
• Swallowing difficulties
• Dizziness or vertigo
• Hearing loss or abnormality
• Numbness
• Pain outside of trigeminal nerve distribution
• Visual changes
Trigeminal Neuralgia: Red flags (History)
24. • Abnormal neurologic examination
• Abnormal oral, dental, or ear examination
• Loss of the corneal reflex
• Any jaw or facial weakness
• Facial hypesthesia or dysesthesia
• Permanent area of numbness
Trigeminal Neuralgia: Red flags (Examination)
25. TN diagnostic criteria - 13.1.1
A. At least 3 attacks of unilateral facial pain fulfilling criteria B and C
B. Occurring in trigeminal nerve distribution, no radiation
C. Three of the following four characteristics:
1. Lasting max. 2 minutes
2. Severe intensity
3. Electric shock-like, shooting or sharp
4. Precipitated by innocuous stimuli to the affected side of the face
D. No clinically evident neurological deficit
E. Not better accounted for by another ICHD 3 diagnosis
Trigeminal Neuralgia: diagnostic criteria ICHD 3-beta
26. A - Paroxysmal attacks of pain lasting from a fraction of a second to 2
minutes, with or without persistence of aching between paroxysms,
affecting 1 or more divisions of the trigeminal nerve and fulfilling criteria B
and C
B - Pain has at least 1 of the following characteristics: (1) intense, sharp,
superficial or stabbing; or (2) precipitated from trigger areas or by trigger
factors C - Attacks stereotyped in the individual patient
D - A causative lesion, other than vascular compression, demonstrated by
special investigations and/or posterior fossa exploration
Symptomatic Trigeminal Neuralgia: diagnostic criteria
27. A - Paroxysmal attacks of pain lasting from a fraction of a second to 2
minutes, with or without persistence of aching between paroxysms,
affecting 1 or more divisions of the trigeminal nerve and fulfilling criteria B
and C
B - Pain has at least 1 of the following characteristics: (1) intense, sharp,
superficial or stabbing; or (2) precipitated from trigger areas or by trigger
factors C - Attacks stereotyped in the individual patient
D - A causative lesion, other than vascular compression, demonstrated by
special investigations and/or posterior fossa exploration
Symptomatic Trigeminal Neuralgia: diagnostic criteria
29. • 53 y old lady presented
with continuous facial
pain involving the whole
right side of the face.
• Her neurological
examination was
entirely unrevealing.
Case 2
30. Case 2
Right Trigeminal Nerve
Compressing vessel
• 53 y old lady presented
with continuous facial
pain involving the whole
right side of the face.
• Her neurological
examination was
entirely unrevealing.
35. • Demyelinated sensory neurons: hyperexitability
and ectopic pacemaker sites.
• Neuron-to-neuron cross-excitation due to eroded
insulation – amplification and synchronization.
• Ephaptic transmission and crossed after
discharge between non-nociceptive afferents and
nociceptive afferents may explain how innocuous
sensory stimuli can trigger painful paroxysms
Devor et al. 2002
Pathophysiology – “the ignition hypothesis”
36. • 54 y old lady presented with recurrent bouts of left sided paroxysmal
facial pain lasting for seconds.
• Her neurological examination was entirely normal.
• What is your diagnosis?
• Should we ask for MRI Brain?
Case 3
37. • Magnetic resonance imaging
(MRI),using a combination of three
high-resolution sequences, should
be performed as part of the work-up
in TN patients, because no clinical
characteristics can exclude
secondary TN.
EAN 2019 Guidelines
38. • Neurovascular contact plays an
important role in primary TN, but
demonstration of a neurovascular
contact should not be used to
confirm the diagnosis of TN.
• Rather, it may help to decide if and
when a patient should be referred
for microvascular decompression
EAN 2019 Guidelines
39. • If MRI is not possible, trigeminal
reflexes can be used.
EAN 2019 Guidelines
40. CONTINUUM: Lifelong Learning in Neurology 23(2):396-420, April 2017.
Trigeminal reflex test to disclose secondary trigeminal
neuralgia
60. • Lamotrigine, gabapentin, botulinum
toxin type A, pregabalin, baclofen,
and phenytoin may be used either
alone or as add-on therapy.
EAN 2019 Guidelines
64. EAN 2019 Guidelines
• Patients should be offered surgery if
pain is not sufficiently controlled
medically or if medical treatment is
poorly tolerated
• In patients with classical TN,
microvascular decompression is
recommended as first-line surgery
66. Microvascular decompression:
– Requires general anesthesia.
– 2.5- to 3-cm craniectomy is performed, the dura is opened, and the
cerebellum is microsurgically retracted.
– Typically, an artery or other vascular cross-compression of the nerve
is identified, the vascular structure is padded away from the nerve
with polytetrafluoroethylene (Teflon) felt.
– This operation has a low mortality rate 0.1 and 0.5% in most series.
– Serious morbidity probably between 1 and 5%.
• Numbness, hearing loss, dizziness, cerebellar syndrome, CSF leaks,
meningitis, diplopia.
Surgical Treatment of TN
67. • MVD is the ONLY non-destructive procedure for the treatment of TN
• Low risk of facial sensory loss with subsequent dysesthesias or
anesthesia dolorosa
• ONLY operation that addresses what is believed to be the primary
underlying pathology; i.e. vascular compression
• Long-term results are at least equivalent if not superior to any other
procedure
Advantages of MVD
68. • Requires major surgery – may not be suitable for patients with significant
medical co-morbidity
• MVD is generally associated with more risks than percutaneous
procedures or radiosurgery
• More costly than percutaneous procedures
Disadvantages of MVD
70. Percutaneous procedures:
– Less risk
– Local or brief general anesthesia
– A needle or trocar is inserted on the cheek just lateral to the corner of
the mouth, under fluoroscopic guidance, introduced into the ipsilateral
foramen ovale.
– Gangliolysis is performed.
– Different types of procedure:
• Percutaneous radiofrequency trigeminal gangliolysis (PRTG).
• Percutaneous retrogasserian glycerol rhizotomy (PRGR).
• Percutaneous balloon microcompression (PBM).
Surgical Treatment of TN
79. Gasserian ganglion percutaneous techniques Success Rates 1:
• Initial: 90%
• 12 months: 68-85%
• 36 months: 54-64%
• 60 months: 50%
MVD Success Rates 2:
• Initial: 90%
• 12 months: 80%
• 36 months: 75%
• 60 months: 73%
1 year after gamma knife therapy, complete pain relief with no medication occurs in up to 69%
of patients. This falls to 52% at 3 years 3.
1 Obermann M et al. Expert Review of Neuropathics. 2009;7:323-330. Zakrzewska JM et al. Pain. 1999;79:51-58
2 Obermann M et al. Expert Review of Neuropathics. 2009;7:323-330. Barker FG 2nd et al. N Eng J Med. 1996;334:1077-1082
Gronseth G, Cruccu G, Alksne J, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology
and the European Federation of Neurological Societies.
Prognosis after TN surgeries